Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1491 (LINC01491) is a human gene that encodes a long intergenic non-coding RNA (lincRNA) [1]. LincRNAs are a subclass of long non-coding RNAs (lncRNAs) that do not overlap with protein-coding genes and are involved in diverse aspects of gene regulation, often modulating transcription and chromatin state [3][5]. LINC01491 itself is not well characterized; its function and mechanism in human biology remain largely unknown. Recent genome-wide association studies (GWAS) have identified genetic variants in the LINC01491 locus associated with increased risk for conditions such as pulmonary arterial hypertension, suggesting a potential, though unconfirmed, role in disease pathogenesis; further research is needed to clarify its biological function and clinical relevance [2]. There are currently no known drugs or therapeutic interventions that specifically target LINC01491.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1491 (LINC01491).